Authors:
SEBIRE K
MCGAVIN K
LAND S
MIDDLETON T
BIRCH C
Citation: K. Sebire et al., STABILITY OF HUMAN-IMMUNODEFICIENCY-VIRUS RNA IN BLOOD SPECIMENS AS MEASURED BY A COMMERCIAL PCR-BASED ASSAY, Journal of clinical microbiology, 36(2), 1998, pp. 493-498
Authors:
GROBELNY D
CHEN Q
TYSSEN D
TACHEDJIAN G
SEBIRE K
BUCHANAN L
BIRCH C
Citation: D. Grobelny et al., ANTIVIRAL ACTIVITY OF DG-35-VIII, A POTENT INHIBITOR OF THE PROTEASE OF HUMAN-IMMUNODEFICIENCY-VIRUS, Antiviral chemistry & chemotherapy, 8(2), 1997, pp. 99-106
Citation: Ma. Wainberg et C. Birch, PHENOTYPIC AND GENOTYPIC RESISTANCE EMERGENT IN NAIVE HIV-1 PATIENTS TREATED WITH COMBINATIONS OF REVERSE-TRANSCRIPTASE INHIBITORS, AIDS, 10, 1996, pp. 72-72
Authors:
HOOKER DJ
TACHEDJIAN G
SOLOMON AE
GURUSINGHE AD
LAND S
BIRCH C
ANDERSON JL
ROY BM
ARNOLD E
DEACON NJ
Citation: Dj. Hooker et al., AN IN-VIVO MUTATION FROM LEUCINE TO TRYPTOPHAN AT POSITION-210 IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CONTRIBUTES TO HIGH-LEVEL RESISTANCE TO 3'-AZIDO-3'-DEOXYTHYMIDINE, Journal of virology, 70(11), 1996, pp. 8010-8018
Authors:
TACHEDJIAN G
MELLORS J
BAZMI H
BIRCH C
MILLS J
Citation: G. Tachedjian et al., ZIDOVUDINE RESISTANCE IS SUPPRESSED BY MUTATIONS CONFERRING RESISTANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO FOSCARNET, Journal of virology, 70(10), 1996, pp. 7171-7181